LumiraDx
The company develops a portable, multimodal diagnostic system designed for point-of-care testing in primary care and decentralized healthcare settings. The platform utilizes microfluidic technology to perform a variety of tests, including infectious diseases, cardiovascular conditions, diabetes, and coagulation, using capillary blood or swab samples. It provides results within minutes to support clinical decision-making without the need for venous blood collection or specialized laboratory infrastructure.
Funding summary
- Total raised
- €13.4M
- Funding rounds
- 1
Investors in LumiraDx
Investors on record for LumiraDx. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like LumiraDx?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors